Market Trends– category –
-
Clair Health Secures $11.6 Million for Wearable Biosensor Device to Deliver Non-Invasive Continuous Hormone Monitoring
OpenLoop Health USA Overview Women's health startup Clair Health has successfully raised $11.6 million in funding to accelerate the development of a wearable device for continuous, non-invasive hormone monitoring. This innovative device ... -
Roche Diagnostics Expands Focus on Diabetes Care, Awaiting US Approval for Accu-Chek Smartguide CGM
Indianapolis Business Journal USA Overview Swiss pharmaceutical giant Roche is continuing its expansion project within its diagnostics division in Indianapolis, with an intensified focus on diabetes care. The company is particularly awai... -
Novel Plasmonic Sensor Detects Aflatoxin M1 Contamination in Milk at 0.005 ng/mL, Enhancing Food Safety Monitoring
AZoSensors Australia Overview A new plasmonic graphene oxide-based aptasensor has been reported to detect Aflatoxin M1 (AFM1) contamination in milk at ultra-low concentrations of 0.005 ng/mL. This innovative sensor significantly enhances... -
Smartwatch-Derived Digital Biomarkers Predict Pace of Biological Aging: Garmin Device Data Reveals New Insights
MDPI Switzerland Overview A recent study published in MDPI demonstrates that smartwatch-derived digital biomarkers from Garmin wearable devices are strongly associated with the pace of biological aging in community-dwelling older adults.... -
Imunopharm Files for Shanghai STAR Market IPO, Targeting $550 Million Valuation to Expand CAR-T and CDMO Business
VCBeat China Overview Chinese biotechnology firm Imunopharm has filed for an Initial Public Offering (IPO) on the Shanghai STAR Market, targeting a valuation of 4 billion RMB (approximately $550 million). The company's pipeline includes ... -
Porton Advanced’s UC-MSC Cell Bank for Exosome Manufacturing Receives FDA Drug Master File (DMF) Acceptance
Morningstar USA Overview Porton Advanced, a CDMO, announced that its umbilical cord-derived mesenchymal stem cell (UC-MSC) cell bank for exosome manufacturing has received Drug Master File (DMF) acceptance from the U.S. FDA. This accepta... -
Curocell’s Rimqarto, South Korea’s First Homegrown CAR-T, Clears Initial Hurdle for National Health Insurance Reimbursement
KBR (Korea Biomedical Review) South Korea Overview Curocell's Rimqarto (anbalcabtagene autoleucel), South Korea's first domestically developed CAR-T cell therapy, has successfully cleared its initial major step towards national health in... -
3D Bioprinting Market Projected to Reach $6.21 Billion by 2030 Driven by Personalized Medicine and Organ Demand
The Business Research Company (via OpenPR) Unknown Overview This article provides an overview of a market research report published by The Business Research Company. The 3D bioprinting market is projected to expand to $6.21 billion by 20... -
Addressing Bottlenecks in Cell and Gene Therapy Manufacturing: Urgent Need for Quality Control and Supply Chain Optimization
Drug Discovery News USA Overview Cell and gene therapy (CGT) manufacturing faces significant bottlenecks, particularly in autologous cell therapies, due to logistical delays and complex quality control challenges. Frequent issues arise w... -
Unicorn Bioscience Report Projects Regenerative Medicine Market to Reach $58.4 Billion in 2026, Scaling to $360 Billion by 2034
Unicorn Bioscience USA Overview Unicorn Bioscience has published a market research report projecting the regenerative medicine market to reach approximately $58.4 billion in 2026, with an anticipated surge to $360 billion by 2034. This g...
